Apotheca Biosciences announced the incorporation of its newly created subsidiary ProMED Biosciences, Inc. ProMED Biosciences will ship their newest flag-ship pharma grade CBD product line under the trademarked brand name ProMED. Company expects substantial revenue potential from ProMED subsidiary with close to $500,000 in preorders so far. ProMED Biosciences will be the Company’s consumer product division carrying cannabinoids and particularly cannabidiol(CBD) related products from tinctures to water and cosmetics. ProMED will be distributed nationally in wellbeing centers, dispensaries, spas, health food stores, vitamin shops, health care providers, online and through distributors. ProMED will initially carry 11 product SKUs which includes: 500 mg 30 ml CBD Oil Drops (Isolate); 500 mg 30 ml CBD Oil Drops (Full Spectrum); 1000 mg 30 ml CBD Tincture (Isolate); 1000 mg 30 ml CBD Tincture (Full Spectrum); 250 mg 3.4oz Air Pump Pain Cream (Isolate); 250 mg 3.4oz Air Pump Pain Cream (Full Spectrum); 25 mg Soft Gel Capsule 30 count bottle (Isolate); 25 mg Soft Gel Capsule 30 count bottle (Full Spectrum); 25 mg Dry Cap Sleep Aid 30 count bottle (Isolate); 500 mg OTC Sport Pain Cream (Isolate); 320 mg OTC Sport Pain Balm Stick (Isolate); and Full Traceability and Transparency.